Annual Report 2015-2016 > HIV & STIs


We provided support for a study in Zimbabwe of a new vaginal ring with the antiretroviral drug dapivirine, finding that it reduced women’s risk of HIV by nearly a third.

To learn more about our programs working in HIV/AIDS, see Family AIDS Care & Education Services (FACES) and the UCSF-University of Zimbabwe Collaborative Research Programme (UZ-UCSF).

To help us continue making an impact on HIV/AIDS treatment, care and prevention worldwide, make a gift to the Bixby Center.

Photo credit: USAID.